top of page
Writer's picturenDimensionsIP

High Court Restrains Glenmark Pharmaceuticals from Business of Anti-Diabetes Drugs


In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

0 views0 comments

Recent Posts

See All

Comments


bottom of page